PRESS RELEASE published on 10/24/2025 at 15:53, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% stake in Mural Oncology plc as per Form 8.3 with relevant securities details Form 8.3 Relevant Securities The Vanguard Group Stake Disclosure Mural Oncology Plc
PRESS RELEASE published on 10/24/2025 at 15:52, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.04% ownership in JTC plc. Transactions included purchases and sales of 1p ordinary shares Sales Vanguard Group Ownership Disclosure Purchases JTC Plc
PRESS RELEASE published on 10/24/2025 at 15:50, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 5.36% ownership in Just Group plc with 55,694,311 relevant securities. Dealings include sale of 20,902 10p ordinary securities at 2.12 GBP per unit The Vanguard Group, Inc. Securities Dealings Ownership Disclosure Sale Transaction Just Group Plc
PRESS RELEASE published on 10/24/2025 at 15:50, 8 months 28 days ago Organto Foods Announces Intention to Prepay Outstanding Debentures Organto Foods Inc. announces prepayment of convertible debentures to reduce debt, strengthen financial position. Holders can convert to common shares at $0.60/share Common Shares Financial Position Convertible Debentures Organto Foods Inc. Prepayment
PRESS RELEASE published on 10/24/2025 at 15:48, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% stake in Spire Healthcare Group plc. Position disclosed on 24-Oct-2025 under Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group Stake Disclosure Spire Healthcare Group
PRESS RELEASE published on 10/24/2025 at 15:47, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc The Vanguard Group, Inc. makes a Form 8.3 disclosure related to Big Yellow Group plc, revealing 5.54% ownership of 10p ordinary shares on 23 Oct 2025 Form 8.3 The Vanguard Group Ownership Disclosure 10p Ordinary Shares Big Yellow Group Plc
PRESS RELEASE published on 10/24/2025 at 15:46, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Alpha Group International plc The Vanguard Group, Inc. discloses 4.48% stake in Alpha Group International plc as of 23 October 2025. Details in Form 8.3 under Takeover Code Rule 8.3 Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Alpha Group International Plc
PRESS RELEASE published on 10/24/2025 at 15:44, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.35% stake in Greencore Group plc. Form 8.3 filing for securities holding Form 8.3 Disclosure The Vanguard Group Securities Holding Greencore Group Plc
PRESS RELEASE published on 10/24/2025 at 15:43, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses 1.66% ownership of Bakkavor Group plc shares. Disclosure made on 24 Oct 2025 The Vanguard Group Ownership Disclosure Financial Disclosure Stock Market Bakkavor Group Plc
PRESS RELEASE published on 10/24/2025 at 15:41, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.96% ownership in Unite Group plc. Dealings include selling 8,501 securities at 5.93 GBP per unit on 24-Oct-2025 Vanguard Group Ownership Disclosure Dealings Unite Group Plc Securities Selling
Published on 07/22/2026 at 15:00, 18 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 18 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 43 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 48 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 15:00, 18 minutes ago Sunday Hotels Opens 24 New Hotels & Resorts in Germany
Published on 07/22/2026 at 14:48, 29 minutes ago Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
Published on 07/22/2026 at 14:43, 34 minutes ago EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
Published on 07/22/2026 at 08:03, 7 hours 15 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 7 hours 18 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
Published on 07/22/2026 at 07:00, 8 hours 18 minutes ago TINC invests in 2 battery energy storage systems developed by BSTOR, and strengthens its role in the Belgian energy transition
